 | AbCellera Biologics (NASDAQ:ABCL) Trading 3.9% Higher
americanbankingnews.com - June 11 at 10:46 AM |
 | AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares
finance.yahoo.com - June 10 at 7:46 PM |
| Andrew Booth Sells 1,200,000 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) Stock
americanbankingnews.com - June 10 at 5:34 PM |
| AbCellera Biologics Inc. (NASDAQ:ABCL) Major Shareholder Holdings Ltd. Thermopylae Sells 5,598,420 Shares
americanbankingnews.com - June 10 at 5:34 PM |
| AbCellera Biologics Inc. (NASDAQ:ABCL) CEO Sells $144,780,000.00 in Stock
americanbankingnews.com - June 10 at 5:34 PM |
| AbCellera Biologics (NASDAQ:ABCL) Shares Gap Up to $23.84
americanbankingnews.com - June 10 at 11:35 AM |
| AbCellera Biologics (NASDAQ:ABCL) Sees Strong Trading Volume
americanbankingnews.com - June 9 at 10:50 AM |
| AbCellera Biologics (NASDAQ:ABCL) Shares Down 6.4%
americanbankingnews.com - June 3 at 3:35 PM |
| AbCellera Biologics (NASDAQ:ABCL) Stock Price Down 7.7%
americanbankingnews.com - May 26 at 12:29 PM |
| AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Consensus Recommendation of "Buy" from Brokerages
americanbankingnews.com - May 22 at 10:24 AM |
|
 | AbCellera Biologics Breaks Below 200-Day Moving Average - Notable for ABCL
nasdaq.com - May 19 at 4:20 PM |
| These Analysts Just Made A Huge Downgrade To Their AbCellera Biologics Inc. (NASDAQ:ABCL) EPS Forecasts
nasdaq.com - May 16 at 7:43 PM |
 | AbCellera Biologics Inc. (ABCL) CEO Carl Hansen on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 12:42 AM |
| AbCellera to Present Virtually at Berenberg Conference on May 18, 2021
finance.yahoo.com - May 11 at 4:16 PM |
| AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy
finance.yahoo.com - May 6 at 6:04 PM |
| New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
finance.yahoo.com - May 4 at 10:55 AM |
| AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals
finance.yahoo.com - April 29 at 6:01 PM |
| AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021
finance.yahoo.com - April 21 at 5:00 PM |
| Is ABCL Stock A Buy or Sell?
finance.yahoo.com - April 20 at 3:54 PM |
| AbCellera to Present Virtually at Upcoming Investor Conferences
finance.yahoo.com - April 12 at 7:12 PM |
| Published Peer-Reviewed Data Demonstrate Bamlanivimab’s High Potency Against SARS-CoV-2 and Support its Use as a Foundational Antibody Therapy to Treat and Prevent COVID-19
finance.yahoo.com - April 5 at 5:40 PM |
| These Analysts Just Made An Incredible Downgrade To Their AbCellera Biologics Inc. (NASDAQ:ABCL) EPS Forecasts
nasdaq.com - April 2 at 9:21 AM |
| AbCellera Biologics Inc. (NASDAQ:ABCL) Analysts Just Cut Their EPS Forecasts Substantially
finance.yahoo.com - April 1 at 1:32 PM |
| AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration
finance.yahoo.com - April 1 at 1:32 PM |
| AbCellera Biologics' (ABCL) CEO Carl Hansen on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 31 at 8:15 PM |
| AbCellera Biologics EPS misses by $0.14, beats on revenue
seekingalpha.com - March 31 at 3:14 PM |
| AbCellera Reports Full Year 2020 Business Results
finance.yahoo.com - March 29 at 8:15 PM |
| What Percentage Of AbCellera Biologics Inc. (NASDAQ:ABCL) Shares Do Insiders Own?
finance.yahoo.com - March 13 at 9:26 AM |
|
| EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients
finance.yahoo.com - March 5 at 7:53 PM |
| AbCellera Biologics Enters Oversold Territory (ABCL)
nasdaq.com - March 4 at 1:46 PM |
| AbCellera Appoints Ester Falconer, Ph.D., as Chief Technology Officer
finance.yahoo.com - February 11 at 8:12 PM |
 | The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
msn.com - February 10 at 8:16 AM |
| AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Receives FDA Emergency Use Authorization for COVID-19
finance.yahoo.com - February 9 at 10:15 PM |
| AbCellera Announces Date of Fourth Quarter 2020 Financial Results Conference Call
finance.yahoo.com - February 3 at 6:00 PM |
 | AbCellera Biologics Inc. (ABCL)
uk.finance.yahoo.com - January 28 at 11:16 PM |
| AbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19
finance.yahoo.com - January 27 at 9:11 AM |
| AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%
finance.yahoo.com - January 26 at 8:39 AM |
| AbCellera Granted U.S. Patent Covering its Trianni Mouse® Technology
finance.yahoo.com - January 19 at 6:45 PM |
 | AbCellera Biologics, Inc. (ABCL)
realmoney.thestreet.com - January 7 at 1:11 AM |
| 2020 Canadian IPO mixed results - number (77) down, amount ($5.55B) up driven by PE-backed IPOs
finance.yahoo.com - January 5 at 2:01 PM |
| Why Is It Moving? Analyzing The Downward Movement in AbCellera Biologics's Stock Today
msn.com - December 29 at 1:20 PM |
 | AbCellera Biologics Inc.
barrons.com - December 28 at 12:21 AM |
| AbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New Mexico
finance.yahoo.com - December 21 at 9:42 AM |
| AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 16 at 12:46 AM |
